A study by Ahn et al (119) reported that ginsenoside Rf can decrease the production of IL-1β, IL-6, TNF-a, NO, and ROS, mediators that are highly activated in IBD, in TNF-α stimulated intestinal epithelial cells and macrophages. Here, TNF is linked to inflammatory bowel disease.